Medical Treatment for Endometriosis: One Size Does Not Fit All - PubMed
3 hours ago
- #hormonal-therapy
- #endometriosis-treatment
- #personalized-medicine
- Endometriosis treatment should integrate evidence, clinical expertise, and patient values.
- First-line hormonal therapies include progestogens and estrogen-progestogen combinations; second-line includes GnRH agonists and antagonists.
- Use body-identical estrogens over ethinyl-estradiol to reduce thrombosis risk and avoid stimulating lesions.
- Irregular bleeding is a main adverse effect of first-line treatments, affecting efficacy and adherence.
- If first-line therapies fail to improve quality of life, switch to GnRH analogues with add-back therapy.
- Add-back therapy should be tailored individually, with transdermal estradiol recommended in combinations.
- GnRH agonists and antagonists yield similar outcomes; neuromodulatory drugs for neuropathic pain show limited effectiveness.
- Treatment success relies on achieving ovariostasis and amenorrhea; failure should only be declared after shifting from first- to second-line.
- Early hormonal intervention in adolescents and young women can improve quality of life and preserve fertility.